126 related articles for article (PubMed ID: 15224804)
1. Treatment of hyperphosphatemia, secondary hyperparathyroidism and hypocalcemia with calcium carbonate favorably modulates vaccination response in uremic rats.
Hannula PM; Pörsti IH; Saha HH; Kalliovalkama J; Jolma PM; Kööbi P; Olander RM; Antonen JA
Clin Nephrol; 2004 Jun; 61(6):406-12. PubMed ID: 15224804
[TBL] [Abstract][Full Text] [Related]
2. Treatment of secondary hyperparathyroidism by high calcium diet is associated with enhanced resistance artery relaxation in experimental renal failure.
Jolma P; Kööbi P; Kalliovalkama J; Saha H; Fan M; Jokihaara J; Moilanen E; Tikkanen I; Pörsti I
Nephrol Dial Transplant; 2003 Dec; 18(12):2560-9. PubMed ID: 14605278
[TBL] [Abstract][Full Text] [Related]
3. Renal insufficiency-induced bone loss is associated with an increase in bone size and preservation of strength in rat proximal femur.
Jokihaara J; Järvinen TL; Jolma P; Kööbi P; Kalliovalkama J; Tuukkanen J; Saha H; Sievänen H; Kannus P; Pörsti I
Bone; 2006 Aug; 39(2):353-60. PubMed ID: 16584934
[TBL] [Abstract][Full Text] [Related]
4. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
5. Sevelamer hydrochloride attenuates kidney and cardiovascular calcifications in long-term experimental uremia.
Cozzolino M; Staniforth ME; Liapis H; Finch J; Burke SK; Dusso AS; Slatopolsky E
Kidney Int; 2003 Nov; 64(5):1653-61. PubMed ID: 14531797
[TBL] [Abstract][Full Text] [Related]
6. The effects of sevelamer hydrochloride and calcium carbonate on kidney calcification in uremic rats.
Cozzolino M; Dusso AS; Liapis H; Finch J; Lu Y; Burke SK; Slatopolsky E
J Am Soc Nephrol; 2002 Sep; 13(9):2299-308. PubMed ID: 12191974
[TBL] [Abstract][Full Text] [Related]
7. Progressive accumulation of lanthanum in the liver of normal and uremic rats.
Slatopolsky E; Liapis H; Finch J
Kidney Int; 2005 Dec; 68(6):2809-13. PubMed ID: 16316357
[TBL] [Abstract][Full Text] [Related]
8. Zinc nutritional status modifies renal osteodystrophy in uremic rats.
Kimmel PL; Langman CB; Bognar B; Faugere MC; Chawla LS; Watkins DW; Malluche HH
Clin Nephrol; 2001 Dec; 56(6):445-58. PubMed ID: 11770796
[TBL] [Abstract][Full Text] [Related]
9. High-calcium vs high-phosphate intake and small artery tone in advanced experimental renal insufficiency.
Kööbi P; Vehmas TI; Jolma P; Kalliovalkama J; Fan M; Niemelä O; Saha H; Kähönen M; Ylitalo P; Rysä J; Ruskoaho H; Pörsti I
Nephrol Dial Transplant; 2006 Oct; 21(10):2754-61. PubMed ID: 16837509
[TBL] [Abstract][Full Text] [Related]
10. Hyperphosphatemia modestly retards parathyroid hormone suppression during calcitriol-induced hypercalcemia in normal and azotemic rats.
Jara A; Chacón C; Felsenfeld AJ
Nephron; 2002 Dec; 92(4):883-8. PubMed ID: 12399635
[TBL] [Abstract][Full Text] [Related]
11. Autoregulation in the parathyroid glands by PTH/PTHrP receptor ligands in normal and uremic rats.
Lewin E; Garfia B; Almaden Y; Rodriguez M; Olgaard K
Kidney Int; 2003 Jul; 64(1):63-70. PubMed ID: 12787396
[TBL] [Abstract][Full Text] [Related]
12. Hyperphosphatemia aggravates cardiac fibrosis and microvascular disease in experimental uremia.
Amann K; Törnig J; Kugel B; Gross ML; Tyralla K; El-Shakmak A; Szabo A; Ritz E
Kidney Int; 2003 Apr; 63(4):1296-301. PubMed ID: 12631346
[TBL] [Abstract][Full Text] [Related]
13. Effect of paricalcitol and cinacalcet on serum phosphate, FGF-23, and bone in rats with chronic kidney disease.
Finch JL; Tokumoto M; Nakamura H; Yao W; Shahnazari M; Lane N; Slatopolsky E
Am J Physiol Renal Physiol; 2010 Jun; 298(6):F1315-22. PubMed ID: 20200094
[TBL] [Abstract][Full Text] [Related]
14. Up-regulation of Cbfa1 and Pit-1 in calcified artery of uraemic rats with severe hyperphosphataemia and secondary hyperparathyroidism.
Mizobuchi M; Ogata H; Hatamura I; Koiwa F; Saji F; Shiizaki K; Negi S; Kinugasa E; Ooshima A; Koshikawa S; Akizawa T
Nephrol Dial Transplant; 2006 Apr; 21(4):911-6. PubMed ID: 16384827
[TBL] [Abstract][Full Text] [Related]
15. How dietary phosphate, renal failure and calcitriol administration affect the serum calcium-phosphate relationship in the rat.
Jara A; Chacón C; Felsenfeld AJ
Nephrol Dial Transplant; 2002 May; 17(5):765-71. PubMed ID: 11981061
[TBL] [Abstract][Full Text] [Related]
16. Assessment of effects of lanthanum carbonate with and without phosphate supplementation on bone mineralization in uremic rats.
Damment SJ; Shen V
Clin Nephrol; 2005 Feb; 63(2):127-37. PubMed ID: 15730055
[TBL] [Abstract][Full Text] [Related]
17. Effect of 2-methylene-19-nor-(20S)-1 alpha-hydroxy-bishomopregnacalciferol (2MbisP), an analog of vitamin D, on secondary hyperparathyroidism.
Slatopolsky E; Finch JL; Brown AJ; Ritter CS; Mizobuchi M; Plum LA; Clagett-Dame M; Sicinski RR; DeLuca HF
J Bone Miner Res; 2007 May; 22(5):686-94. PubMed ID: 17444814
[TBL] [Abstract][Full Text] [Related]
18. Chronic metabolic acidosis in azotemic rats on a high-phosphate diet halts the progression of renal disease.
Jara A; Felsenfeld AJ; Bover J; Kleeman CR
Kidney Int; 2000 Sep; 58(3):1023-32. PubMed ID: 10972667
[TBL] [Abstract][Full Text] [Related]
19. Trabecular bone volume and osteoprotegerin expression in uremic rats given high calcium.
Rianthavorn P; Ettenger RB; Salusky IB; Kuizon BD
Pediatr Nephrol; 2010 Nov; 25(11):2311-9. PubMed ID: 20676692
[TBL] [Abstract][Full Text] [Related]
20. Differential effects of vitamin D receptor activators on aortic calcification and pulse wave velocity in uraemic rats.
Noonan W; Koch K; Nakane M; Ma J; Dixon D; Bolin A; Reinhart G
Nephrol Dial Transplant; 2008 Dec; 23(12):3824-30. PubMed ID: 18644798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
